Role of mitochondrial complex III/IV in the activation of transcription factor Rst2 in Schizosaccharomyces pombe

2021 ◽  
Author(s):  
Guanglie Jiang ◽  
Qiannan Liu ◽  
Toshiaki Kato ◽  
Hao Miao ◽  
Xiang Gao ◽  
...  
2008 ◽  
Vol 28 (23) ◽  
pp. 7126-7138 ◽  
Author(s):  
Yutaka Shima ◽  
Takito Shima ◽  
Tomoki Chiba ◽  
Tatsuro Irimura ◽  
Pier Paolo Pandolfi ◽  
...  

ABSTRACT PML, a nuclear protein, interacts with several transcription factors and their coactivators, such as HIPK2 and p300, resulting in the activation of transcription. Although PML is thought to achieve transcription activation by stabilizing the transcription factor complex, little is known about the underlying molecular mechanism. To clarify the role of PML in transcription regulation, we purified the PML complex and identified Fbxo3 (Fbx3), Skp1, and Cullin1 as novel components of this complex. Fbx3 formed SCFFbx3 ubiquitin ligase and promoted the degradation of HIPK2 and p300 by the ubiquitin-proteasome pathway. PML inhibited this degradation through a mechanism that unexpectedly did not involve inhibition of the ubiquitination of HIPK2. PML, Fbx3, and HIPK2 synergistically activated p53-induced transcription. Our findings suggest that PML stabilizes the transcription factor complex by protecting HIPK2 and p300 from SCFFbx3-induced degradation until transcription is completed. In contrast, the leukemia-associated fusion PML-RARα induced the degradation of HIPK2. We discuss the roles of PML and PML-retinoic acid receptor α, as well as those of HIPK2 and p300 ubiquitination, in transcriptional regulation and leukemogenesis.


2008 ◽  
Vol 22 (S1) ◽  
Author(s):  
Christian Cortés‐Rojo ◽  
Elizabeth Calderón‐Cortés ◽  
Mónica Clemente‐Guerrero ◽  
Salvador Manzo‐Ávalos ◽  
Alfredo Saavedra‐Molina

Biochemistry ◽  
2006 ◽  
Vol 45 (30) ◽  
pp. 9042-9052 ◽  
Author(s):  
Tina Wenz ◽  
Petra Hellwig ◽  
Fraser MacMillan ◽  
Brigitte Meunier ◽  
Carola Hunte

2021 ◽  
Vol 22 (19) ◽  
pp. 10200
Author(s):  
Agata Sakowicz ◽  
Michalina Bralewska ◽  
Tadeusz Pietrucha ◽  
Francesc Figueras ◽  
Dominika E. Habrowska-Górczyńska ◽  
...  

Preeclampsia is a pregnancy disorder associated with shallow placentation, forcing placental cells to live in hypoxic conditions. This activates the transcription factor kappa B (NFκB) in maternal and placental cells. Although the role of NFκB in preeclampsia is well documented, its mechanism of activation in trophoblastic cells has been never studied. This study investigates the mechanism of NFκB activation in a first trimester trophoblastic cell line (HTR8/SVneo) stimulated by a medium containing serum from preeclamptic (PE) or normotensive (C) women in hypoxic (2% O2) or normoxic (8% O2) conditions. The results indicate that in HTR8/SVneo cells, the most widely studied NFκB pathways, i.e., canonical, non-canonical and atypical, are downregulated in environment PE 2% O2 in comparison to C 8% O2. Therefore, other pathways may be responsible for NFκB activation. One such pathway depends on the activation of NFκB by the p53/RSK1 complex through its phosphorylation at Serine 536 (pNFκB Ser536). The data generated by our study show that inhibition of the p53/RSK1 pathway by p53-targeted siRNA results in a depletion of pNFκB Ser536 in the nucleus, but only in cells incubated with PE serum at 2% O2. Thus, the p53/RSK1 complex might play a critical role in the activation of NFκB in trophoblastic cells and preeclamptic placentas.


2000 ◽  
Vol 29 (2) ◽  
pp. 170-180 ◽  
Author(s):  
Sandeep Raha ◽  
Gillian E McEachern ◽  
A.Tomoko Myint ◽  
Brian H Robinson

Sign in / Sign up

Export Citation Format

Share Document